Compare NKTX & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | SPAI |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.7M | 139.4M |
| IPO Year | 2020 | 2024 |
| Metric | NKTX | SPAI |
|---|---|---|
| Price | $1.81 | $4.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $13.25 | $10.00 |
| AVG Volume (30 Days) | ★ 684.9K | 208.4K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,266,756.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $538.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $1.47 |
| 52 Week High | $3.16 | $9.16 |
| Indicator | NKTX | SPAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 42.83 |
| Support Level | $1.77 | $4.03 |
| Resistance Level | $1.93 | $5.14 |
| Average True Range (ATR) | 0.09 | 0.42 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 30.00 | 65.62 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.